110 related articles for article (PubMed ID: 16773806)
1. [Approved indications of the positron emission tomography (PET) in Spain: controlled use].
Carreras Delgado JL
An R Acad Nac Med (Madr); 2002; 119(4):655-61; discussion 687-731. PubMed ID: 16773806
[TBL] [Abstract][Full Text] [Related]
2. [Tutelage use of positron emission tomography (PET): difficulties and controversies].
Gómez Fernández I; Almoguera Arias I; Alonso Farto JC; Durán Barquero C; Ramos Moreno E; Domínguez Montero P; Bittini Copano A; Pérez Vázquez JM
Rev Esp Med Nucl; 2004; 23(6):429-33. PubMed ID: 15625063
[No Abstract] [Full Text] [Related]
3. [CT-PET: a new light in the diagnostic tunnel].
Carreras Delgado JL
An R Acad Nac Med (Madr); 2006; 123(3):649-54; discussion 654-7. PubMed ID: 17451103
[TBL] [Abstract][Full Text] [Related]
4. [Update of the recommendations of good clinical practice for the use of PET in oncology].
Salaün PY; Abgral R; Malard O; Querellou-Lefranc S; Quere G; Wartski M; Coriat R; Hindie E; Taieb D; Tabarin A; Girard A; Grellier JF; Brenot-Rossi I; Groheux D; Rousseau C; Deandreis D; Alberini JL; Bodet-Milin C; Itti E; Casasnovas O; Kraeber-Bodere F; Moreau P; Philip A; Balleyguier C; Lucian A; Cachin F
Bull Cancer; 2019 Mar; 106(3):262-274. PubMed ID: 30683308
[TBL] [Abstract][Full Text] [Related]
5. [Understanding positon emission tomography (PET) with [18F]-FDG in clinical oncology. Informations dedicated to patients and relatives].
Bourguet P; Brusco S; Corone C; Devillers A; Foehrenbach H; Lumbroso JD; Maszelin P; Montravers F; Moretti JL; Rain JD; Talbot JN; Carretier J; Leichtnam-Dugarin L; Delavigne V; Philip T; Fervers B; ; ; ; ; ; ;
Bull Cancer; 2005 Jul; 92(7):723-32. PubMed ID: 16123010
[TBL] [Abstract][Full Text] [Related]
6. [Epidemiological study on PET cancer screening].
Senda M; Inoue T; Uno K; Jinnouchi M; Tsukamoto E; Terauchi T; Nakajima R; Nishizawa S; Minamimoto R; Yoshida T
Kaku Igaku; 2009 Jun; 46(2):100-2. PubMed ID: 19791309
[No Abstract] [Full Text] [Related]
7. [Positron emission tomography 2013 in Germany. Results of the query and current status].
Kotzerke J; Oehme L; Grosse J; Hellwig D;
Nuklearmedizin; 2015; 54(2):53-9. PubMed ID: 25650552
[TBL] [Abstract][Full Text] [Related]
8. [Positron emission tomography--a technique for the routine practice of ambulatory care?].
Gibis B; Rheinberger P; Sander G; Kirkowa-Reimann M; Schmacke N; Gawlik C
Z Arztl Fortbild Qualitatssich; 2003 Apr; 97(2):151-6. PubMed ID: 12806822
[TBL] [Abstract][Full Text] [Related]
9. Appropriate indications for positron emission tomography/computed tomography, 2015.
Vorster M; Doruyter A; Brink A; Mkhize S; Holness J; Malan N; Nyakale N; Warwick JM; Sathekge M;
S Afr Med J; 2015 Oct; 106(1 Pt 2):105-22. PubMed ID: 26792318
[TBL] [Abstract][Full Text] [Related]
10. [Reimbursement of the PET in oncology in Europe: a questionnaire based survey].
Dietlein M; Schicha H
Nuklearmedizin; 2003 Jun; 42(3):80-5. PubMed ID: 12802468
[TBL] [Abstract][Full Text] [Related]
11. [Positron emission tomography 2008 in Germany - results of the query and current status].
Kotzerke J; Oehme L; Lindner O; Hellwig D;
Nuklearmedizin; 2010; 49(2):58-64. PubMed ID: 20198277
[TBL] [Abstract][Full Text] [Related]
12. FDG PET/CT in oncology: "raising the bar".
Patel CN; Goldstone AR; Chowdhury FU; Scarsbrook AF
Clin Radiol; 2010 Jul; 65(7):522-35. PubMed ID: 20541652
[TBL] [Abstract][Full Text] [Related]
13. Best practices: consensus on performing positron emission tomography-computed tomography for radiation therapy planning and for therapy response assessment.
Blodgett T
Semin Ultrasound CT MR; 2010 Dec; 31(6):506-15. PubMed ID: 21147378
[TBL] [Abstract][Full Text] [Related]
14. [Comments on the technical report "PET in Oncology" from the Health Technology Evaluation Agency of the Carlos III Health Institute].
Carreras Delgado JL
Rev Esp Med Nucl; 1998; 17(2):132-7. PubMed ID: 9611286
[No Abstract] [Full Text] [Related]
15. [The status of domestic PET/CT attendance in the light of the waiting list data].
Galuska L; Balkay L
Magy Onkol; 2010 Jun; 54(2):161-8. PubMed ID: 20576593
[TBL] [Abstract][Full Text] [Related]
16. Clinical PET/CT imaging: promises and misconceptions.
Czernin J; Auerbach MA
Nuklearmedizin; 2005; 44 Suppl 1():S18-23. PubMed ID: 16395974
[TBL] [Abstract][Full Text] [Related]
17. Positron emission tomography as an imaging biomarker.
Weber WA
J Clin Oncol; 2006 Jul; 24(20):3282-92. PubMed ID: 16829652
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of PET and PET/CT in oncology: evidence and methodologic approaches.
Buck AK; Herrmann K; Stargardt T; Dechow T; Krause BJ; Schreyögg J
J Nucl Med; 2010 Mar; 51(3):401-12. PubMed ID: 20150250
[TBL] [Abstract][Full Text] [Related]
19. Japanese guideline for the oncology FDG-PET/CT data acquisition protocol: synopsis of Version 1.0.
Fukukita H; Senda M; Terauchi T; Suzuki K; Daisaki H; Matsumoto K; Ikari Y; Hayashi M
Ann Nucl Med; 2010 May; 24(4):325-34. PubMed ID: 20401547
[TBL] [Abstract][Full Text] [Related]
20. [Positron emission tomography (PET) in oncology: a part of medical therapeutic expertise].
Bamberg M; Diehl V; Herrmann T; Jürgens H; Siewert JR; Kotzerke J;
Dtsch Med Wochenschr; 2006 Mar; 131(10):512-5. PubMed ID: 16511743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
